FDA Approves RiVive (naloxone) Over-the-Counter Nasal Spray for the Emergency Treatment of Opioid Overdose Pittsburgh, Pennsylvania–(Newsfile Corp. – July 28,

EAST HANOVER, N.J., July 10, 2023 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has

FDA Approves Rystiggo (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis Brussels (Belgium) June 27 2023 – UCB

Lynparza combination showed a clinically meaningful reduction in risk of disease progression or death in these patients in the Phase

CAMBRIDGE, Mass., May 22, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC) today announced that the U.S. Food and Drug

FDA Approves Opvee (nalmefene hydrochloride) Prescription Nasal Spray to Reverse Opioid Overdose May 22, 2023 — Today, the U.S. Food

The Host Several states have begun the herculean task of redetermining how many of an estimated 85 million Americans currently

https://youtube.com/watch?v=cNnAQD24GFc%3Fversion%3D3%26%23038%3Brel%3D1%26%23038%3Bshowsearch%3D0%26%23038%3Bshowinfo%3D1%26%23038%3Biv_load_policy%3D1%26%23038%3Bfs%3D1%26%23038%3Bhl%3Den-US%26%23038%3Bautohide%3D2%26%23038%3Bwmode%3Dtransparent AMARILLO, Texas — Federal judges in Texas have delivered time and again for abortion opponents. They upheld a state

FDA Approves Syfovre (pegcetacoplan injection) for the Treatment of Geographic Atrophy, a Leading Cause of Blindness WALTHAM, Mass., Feb. 17,

California’s decision last month to cancel the results of a long-planned bidding competition among commercial health plans in its Medicaid